Gina Columbus reports on FDA approvals in hepatocellular carcinoma and cervical cancer, a breakthrough therapy designation in lung cancer, mixed findings in small cell lung cancer, a European approval in chronic lymphocytic leukemia, and how the novel coronavirus 2019 is impacting the schedule of oncology conferences. Website: https://www.onclive.com Twitter: https://twitter.com/OncLive Facebook: https://www.facebook.com/OncLive/ LinkedIn: https://www.linkedin.com/company/onclive
